PFIZER LIMITED - United Kingdom 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:700-800
Total Number of Projects:400-500
2019
Criterium:Position:
Overall Score:400-500
Total Number of Projects:200-300
2018
Criterium:Position:
Overall Score:800-900
Total Number of Projects:300-400
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 47
As coordinator: 0
As participant: 47
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 77.300.110 0 8
2020 0 134.831.192 0 9
2019 0 196.939.080 0 13
2018 0 103.838.674 0 7
2017 0 66.023.667 0 8
2016 0 14.080.000 0 2

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA31
JANSSEN PHARMACEUTICA NV23
SANOFIAVENTIS22
BAYER20
F HOFFMANNLA ROCHE18
UCB BIOPHARMA18
NOVO NORDISK15
KATHOLIEKE UNIVERSITEIT LEUVEN14
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG13
TAKEDA PHARMACEUTICALS INTERNATIONAL13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD13
ABBVIE INC12
ELI LILLY AND COMPANY LIMITED12
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT11
ASTRAZENECA10
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN10
TAKEDA DEVELOPMENT CENTRE EUROPE10
CHARITE UNIVERSITAETSMEDIZIN BERLIN9
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM9
UNIVERSITAIR MEDISCH CENTRUM UTRECHT9
UNIVERSITY OF NEWCASTLE UPON TYNE9
FORUM DES PATIENTS EUROPEENS8
MERCK SHARP & DOHME CORP8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
KAROLINSKA INSTITUTE7
MEDIZINISCHE UNIVERSITAET WIEN7
THE UNIVERSITY OF MANCHESTER7
UNIVERSITY OF DUNDEE7
UPPSALA UNIVERSITET7
ACADEMISCH ZIEKENHUIS GRONINGEN6
LEIDS UNIVERSITAIR MEDISCH CENTRUM6
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN6
STICHTING VUMC6
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL6
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA6
THE UNIVERSITY OF LIVERPOOL6
UNIVERSITY COLLEGE LONDON6
UNIVERSITY OF CAMBRIDGE6
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE5
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS5
KING'S COLLEGE LONDON5
SERVICIO MADRILENO DE SALUD5
STICHTING KATHOLIEKE UNIVERSITEIT5
TEVA PHARMACEUTICAL INDUSTRIES LIMITED5
UNIVERSITAT WIEN5
UNIVERSITATSKLINIKUM ERLANGEN5
UNIVERSITY COLLEGE DUBLIN5
VIB VZW5
ACADEMIC MEDICAL CENTRE AMSTERDAM4
ASTELLAS PHARMA EUROPE BV4
ASTRAZENECA AB4
BRISTOLMYERS SQUIBB COMPANY CORP4
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS4
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL4
ELI LILLY AND COMPANY4
EUROPEAN CANCER PATIENT COALITION4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE4
INSTITUT DE RECHERCHES SERVIER4
LUND UNIVERSITY4
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV4
OSPEDALE PEDIATRICO BAMBINO GESU4
TARTU ULIKOOL4
THE UNIVERSITY OF SHEFFIELD4
TTOPSTART BV4
UNIVERSITA CATTOLICA DEL SACRO CUORE4
UNIVERSITA VITASALUTE SAN RAFFAELE4
UNIVERSITAET BERN4
UNIVERSITY OF BIRMINGHAM4
UNIVERSITY OF BOLOGNA4
UNIVERSITY OF COPENHAGEN4
UNIVERSITY OF GLASGOW4
ACADEMISCH ZIEKENHUIS LEIDEN3
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS3
ALLERGAN LIMITED3
AMGEN LIMITED3
ANTAROS MEDICAL AB3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
AUSTRIAN RESEARCH CENTERS SIEBERDORF3
CELGENE MANAGEMENT SARL3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH3
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL3
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION3
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES3
FUJIFILM CELLULAR DYNAMICS INC3
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA3
FUNDACIO SANT JOAN DE DEU3
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA3
GLAXOSMITHKLINE BIOLOGICALS3
GRUNENTHAL3
H LUNDBECK AS3
IXSCIENT LIMITED3
KUNGLIGA TEKNISKA HOEGSKOLAN3
LEIDEN UNIVERSITY3

Constancy:

Total number of partners: 1370
Partner loyalty:
Frequent Partner: (> 2 projects): 714
Rare Partner: 656
Frequent / Rare Partner Ratio: 1.09

Project overview:

Start dateProjectacronymrolefundingpartners
2021-10-01Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies SCREEN4CAREparticipant11.938.56935
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99737
2021-09-01BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe BEAMERparticipant5.948.90330
2021-07-01Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States HIPPOCRATESparticipant10.210.99327
2021-07-01Real World Handling of Protein Drugs - Exploration, Evaluation and Education RealHOPEparticipant3.139.98425
2021-06-01Add medical genetic solutions to RESOLUTE (REsolution) REsolutionparticipant1.000.0009
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82548
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00040
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68723
2020-06-01Stratification of Obesity Phenotypes to Optimize Future Therapy SOPHIAparticipant8.301.00036
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18642
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2020-01-01Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies ImmUniverseparticipant15.500.00027
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99829
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01WEB-RADR 2 WEB-RADR 2participant1.168.75012
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00047
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4participant7.370.00021
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023